Hypoxia-Targeting Multifunctional Nanoparticles for Sensitized Chemotherapy and Phototherapy in Head and Neck Squamous Cell Carcinoma

Código QR

Hypoxia-Targeting Multifunctional Nanoparticles for Sensitized Chemotherapy and Phototherapy in Head and Neck Squamous Cell Carcinoma

Chuanhui Song, 1, 2,* Chuanchao Tang, 1, 2,* Wenguang Xu, 2 Jianchuan Ran, 1, 2 Zheng Wei, 1, 3 Yufeng Wang, 1, 2 Huihui Zou, 1, 2 Wei Cheng, 4 Yu Cai, 1 Wei Han 1, 2 1Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, People&am...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Song C, Tang C, Xu W, Ran J, Wei Z, Wang Y, Zou H, Cheng W, Cai Y, Han W
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	cisplatin metformin chlorin e6 head and neck squamous cell carcinoma nano-delivery Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/80ca1e5766a24408bc932be297b12828
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Treatment Outcomes and the Safety of Chemoradiotherapy With High-Dose CDDP for Elderly Patients With Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Study
por: Jo Omata, et al.
Publicado: (2021)

Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma
por: Farzaneh Kordbacheh, et al.
Publicado: (2021)

Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma
por: Xuanli Xu, et al.
Publicado: (2021)

A Novel Pyroptosis-Related Gene Signature for Prognostic Prediction of Head and Neck Squamous Cell Carcinoma
por: Qian X, et al.
Publicado: (2021)

Imaging Features of Postradiotherapy Changes in Head and Neck Cancers
por: Anisha Gehani, et al.
Publicado: (2021)

The effect of red-allotrope selenium nanoparticles on head and neck squamous cell viability and growth
por: Hassan CE, et al.
Publicado: (2016)

Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
por: Hayashi N, et al.
Publicado: (2021)

Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
por: Philipp Baumeister, et al.
Publicado: (2021)

Clinical Outcomes of Cetuximab and Paclitaxel after Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Shinsuke Suzuki, et al.
Publicado: (2021)

Oral and Oropharyngeal Squamous Cell Carcinoma in Our Population: The Clinic-Pathological and Morphological Description of 153 Cases
por: Agarwal,A. K, et al.
Publicado: (2011)

AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling
por: Fu L, et al.
Publicado: (2021)

Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck
por: Ammar Sukari, et al.
Publicado: (2015)

New Scenarios in Pharmacological Treatments of Head and Neck Squamous Cell Carcinomas
por: Cristina Porcheri, et al.
Publicado: (2021)

Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery
por: Karl Payne, et al.
Publicado: (2021)

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma
por: Xinwen Wang, et al.
Publicado: (2021)

Prevalence of HPV in Mexican Patients with Head and Neck Squamous Carcinoma and Identification of Potential Prognostic Biomarkers
por: Galo Méndez-Matías, et al.
Publicado: (2021)

Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma
por: Xing-xing Huo, et al.
Publicado: (2021)

Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review
por: Lucrezia Togni, et al.
Publicado: (2021)

Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas
por: Pei-Hung Chang, et al.
Publicado: (2021)

Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
por: Ying-Peng Peng, et al.
Publicado: (2021)

Roles of mesenchymal stromal cells in the head and neck cancer microenvironment
por: Marcelo Coutinho de Miranda, et al.
Publicado: (2021)

Well-Differentiated Squamous Cell Carcinoma: Is Histological Differentiation a Relevant Prognostic Parameter?
por: Iago Ferreira, et al.
Publicado: (2021)

The Hidden Link of Exosomes to Head and Neck Cancer
por: Yong Teng, et al.
Publicado: (2021)

Indian journal of otolaryngology and head and neck surgery official publication of the Association of Otolaryngologists of India.
Publicado: (1993)

Rapid response of locally advanced oral squamous cell carcinoma to apatinib: A case report
por: He Jian, et al.
Publicado: (2021)

The role of NEAT1 lncRNA in squamous cell carcinoma of the head and neck is still difficult to define
por: Joanna Kozłowska, et al.
Publicado: (2020)

Targeting miR-185-3p Inhibits Head and Neck Squamous Cell Carcinoma by Modulating RAB25
por: Xueping Wang, et al.
Publicado: (2021)

A Novel Lipid Prognostic Signature of ADCY2, LIPE, and OLR1 in Head and Neck Squamous Cell Carcinoma
por: Xiaolei Gao, et al.
Publicado: (2021)

Identification and Validation of 17-lncRNA Related to Regulatory T Cell Heterogeneity as a Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Qi Sun, et al.
Publicado: (2021)

Osteoradionecrosis in a Patient Submitted to Head and Neck Radiotherapy: A Case Report
por: Ferreira,Karla Daniella Malta, et al.
Publicado: (2019)

The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma
por: Enhao Wang, et al.
Publicado: (2021)

Oro- and pharyngostoma. Relevant questions in head and neck reconstructive surgery
por: S.Y. Karp
Publicado: (2016)

Review of oncological findings and complications after elective neck dissection during total laryngectomy: a case series
por: Mahmoud Elsayed, et al.
Publicado: (2021)

A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy
por: Re-I Chin, et al.
Publicado: (2021)

Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer
por: Adam Luginbuhl, et al.
Publicado: (2021)

EFFICACY OF INDUCTION CHEMOTHERAPY IN LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
por: Muhammad Imran Khan Wajid, et al.
Publicado: (2019)

An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer
por: Tao Wei, et al.
Publicado: (2020)

EFFICACY OF METHOTREXATE IN THE MANAGEMENT OF LOCALLY ADVANCED AND METASTATIC HEAD AND NECK CANCERS
por: Meherullah Tareen, et al.
Publicado: (2019)

Dynamics-Adapted Radiotherapy Dose (DARD) for Head and Neck Cancer Radiotherapy Dose Personalization
por: Mohammad U. Zahid, et al.
Publicado: (2021)

Gene Mutations in Circulating Tumour DNA as a Diagnostic and Prognostic Marker in Head and Neck Cancer—A Systematic Review
por: Markéta Hudečková, et al.
Publicado: (2021)